Targets of v-myc tumorigenesis in the avian embryo depend on time and not on site of retroviral infection.
The present study extends our previous data, showing that the v-myc oncogene induces heart tumors and skin anomalies in young avian embryos [Saule et al., Proc. Natl. Acad. Sci. USA 84, 7982-7986 (1987)]. We now report that the target cells which become transformed are the same, whether the MC29 retrovirus is injected at E3 in various sites of the embryo (coelom, heart, brain, lateral plate mesoderm) or deposited on the embryo. Furthermore we confirm, in the quail, the time-specific pattern previously observed in the chick. In the quail, the incidence of heart tumors falls from 100% to 28% when injection is delayed from E3 to E4. By contrast, the incidence of skin anomalies rises from 30% to 64% when injection is delayed from E3 to E4. The skin defect, which consists of the presence of bell-shaped cornified feathers, could be assigned to hyperkeratinization of the epidermis. Both the dermis and the epidermis displayed hyperproliferation, whereas skin muscle hypertrophy during the embryonic period could not be confirmed. The presence of myc gene products was investigated using an antibody that recognizes both the c- and v-myc proteins. In the skin of control embryos, nuclei were well stained at E12-E13. At E14 the signal had disappeared. In abnormal skin patches from infected embryos, the antibody still marked heavily epidermal and dermal nuclei at E18. Finally we injected MC29 through the chorioallantoic vein in E10 chickens. No tumors were found during embryonic life, but 81% of the chickens developed tumors of hemopoietic or endothelial origin from the 14th posthatching day onwards. Studies of MC29 integration sites demonstrated that these tumors were derived from only a few transformed cells. Thus, contrasting with in vitro experiments, in vivo this virus has a restricted number of targets varying with the time of injection.